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Abstract
Background: Intermediate filaments (IFs) are major components of the mammalian cytoskeleton and expressed in
cell-type-specific patterns. Morphological changes during cell differentiation are linked to IF network remodeling.
However, little is known concerning the presence and the role of IFs in embryonic stem (ES) cells and during their
differentiation.
Results: We have examined the expression profile of synemin isoforms in mouse pluripotent ES cells and during
their neural differentiation induced by retinoic acid. Using RT-PCR, Western blotting and immunostaining, we show
that synemin M is present at both mRNA and protein levels in undifferentiated ES cells as early as pluripotency
factor Oct-3/4 and IF keratin 8. Synemin H was produced only in neural precursors when neural differentiation
started, concurrently with synemin M, nestin and glial fibrillary acidic protein. However, both synemin H and M
were restricted to the progenitor line during the neural differentiation program. Our in vivo analysis also confirmed
the expression of synemins H/M in multipotent neural stem cells in the subventricular zone of the adult brain, a
neurogenic germinal niche of the mice. Knocking down synemin in ES cells by shRNA lentiviral particles
transduction has no influence on expression of Oct4, Nanog and SOX2, but decreased keratin 8 expression.
Conclusions: Our study shows a developmental stage specific regulation of synemin isoforms in ES cells and its
neural derivatives. These findings represent the first evidence that synemins could potentially be useful markers for
distinguishing multipotent ES cells from undifferentiated neural stem cells and more committed progenitor cells.
Background
Synemin belongs to the intermediate filament (IF) pro-
tein family [1,2]. In mammals, the synemin gene is one
of the rare IF genes encoding three isoforms (180, 150
and 41 kDa) achieved by alternative mRNA splicing,
exon skipping and a shift in the open reading frame
[3,4]. The two larger isoforms of synemin (H and M)
harbor extended C-terminal tails that project from the
surface of the filament and provide connecting arms
that associate with neighboring proteins [5-7]. In con-
trast, the small isoform (L) lacks this tail domain [3,8].
Synemin forms obligatory heteropolymers in order to
incorporate into filamentous networks and is associated
with desmin and vimentin in muscle and endothelial
cells [1-3,9]. It has been suggested that synemin could
function as a linker between different cytoskeletal com-
ponents based on the fact that it interacts with several
proteins involved in the organization of the costameres,
neuromuscular and myotendinous junctions within
striated muscle cells. These proteins include a-actinin,
vinculin, dystrophin, a-dystrobrevin, utrophin, zyxin and
talin [1,3-7,10-13]. In addition, it has been reported that
synemin is an A-kinase anchoring protein (AKAP), con-
taining a binding region for protein kinase A (PKA) in
its C-terminal domain which provides temporal and spa-
tial targeting of PKA in cardiomyocytes [14]. In the ner-
vous system, synemin was found to associate with
ruffled membranes of reactive astrocytes and to also co-
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[15]. We have shown that synemins H and M were pre-
sent with vimentin, nestin and glial fibrillary acidic pro-
tein (GFAP) in glial progenitors, whereas the small
isoform appeared in neurons linked to the NF proteins
associated with the membrane compartment [9,16].
The different expression of isoforms H, M and L of
synemin in the nervous system raises several questions
about the regulation of synemin gene expression during
the determination of glial and neuronal cell lineages in
the central and the peripheral nervous system (CNS and
PNS). First, an unexpected finding is the selective synth-
esis of two high molecular weight synemin isoforms (H
and M) in CNS astrocytes, while the smallest synemin
isoform (L) is present only in neurons [16]. This selec-
tivity suggests that the commitment of CNS precursor
cells to form glia or neuron involves the direct regula-
tion of the single synemin gene. Our analysis of mouse
development from embryonic day 5 to 15 (E5 to E15)
has demonstrated that synemin M mRNA is produced
at E5 as early as nestin and vimentin mRNA, prior to
the appearance of the H isoform. In toto hybridization
at E7.5 showed synemin M labeling in the embryonic
mesoderm and the neuroectoderm [9]. We asked if
synemin is also expressed in mouse embryonic stem
(ES) cells, which can differentiate into a variety of
somatic cell types including lineages from three embryo-
nic germ layers? The presence and function of IF pro-
teins in ES cells are not yet fully understood, only a few
members of this family have been studied [17-20]. The
mRNAs coding for keratins 7, 8, 18 and 19 are present
in the 2-cell stage embryo, but only K7 and K8 (type II)
are translated into protein in 4- to 8-cell stage embryos
at a low level, which is deposited in aggregates
[18,19,21-23]. The K18 and K19 proteins were identified
from E3.5 mouse embryo [19,24]. After differentiation of
ES cells into neuronal progenitors, K8 and K18 protein
expression decreased [24]. The nuclear IF protein lamin
B1 and B2 were identified as markers of ES cells; how-
ever the lamins A/C were activated during ES cell differ-
entiation [25].
In this report, we examined the expression profile of
synemin isoforms in mouse pluripotent ES cells and
during their early neural differentiation induced by reti-
noic acid to answer the following questions: 1) Are
synemin isoforms expressed in pluripotent ES cells? 2)
How are synemin isoforms expressed during neural dif-
ferentiation of ES cells? We detected the expression of
synemin M at both mRNA and protein levels in pluripo-
tent ES cells, as early as Oct-3/4 and keratin 8. Synemin
H was produced only in neural precursors when the
neural differentiation started, along with synemin M,
nestin and GFAP.
Results
Synemin M expression in mouse pluripotent ES cells
To investigate which synemin isoforms are expressed in
ES cells, two mouse ES cell lines were used. We first
analyzed the pluripotent state of the cells by PCR-Array.
We identified the expression of transcription factors
maintaining “stem-ness” as Nanog, Nr6a1, Utf1, Pou5f1
(Oct-3/4), and signaling molecules required for pluripo-
tency and self-renewal genes such as Ifitm1 and Pten.
No expression of embryonic stem cell differentiation
genes was detected in the ES cells (Data not shown).
Expression of synemin mRNA in ES cells was analyzed
by RT-PCR. As shown in Figure 1A, we detected the
synemin M mRNA in ES cells. In contrast, neither syne-
min H nor nestin mRNA was found. The E9.5 mouse
embryos containing synemin M and H were used as a
positive control (Figure 1A).
The presence of synemin M protein, but not synemin
H, was confirmed by Western blot analysis in ES cells
(Figure 1B). In the positive control, both synemin M
and H isoforms were identified in the adult mouse blad-
der. The presence of Oct-3/4, a marker of the pluripo-
tency of ES cells, was also confirmed by Western
blotting (Figure 1B). Two-dimensional polyacrylamide
gel electrophoresis (2-D PAGE) followed by Western
blotting was used to further analyze the synemin profile
from ES cells extracts. This experiment showed two
spot trains (a and b) of synemin M with an apparent
molecular weight of 148-150 kDa and isoelectric point
(pI) 5.1-5.2 in each ES cell line (Figure 1C), correspond-
ing to its theoretical pI (5.14), in agreement with its
high content in glutamic acid and glutamine (18%, 228
residues/molecule), aspartic acid (6%, 70 residues/mole-
cule), and rich in serine (9%, 111 residues/molecule) and
poor in cysteine (0.1%, 2 residues/molecule). We could
observe that the quantity of spot train-a of synemin M
was more abundant than spot train-b. In order to inves-
tigate the possible post-translational modifications of
synemin, we analyzed the phosphorylation of synemin
M in ES cells with anti-phosphoserine antibody. This
result revealed that synemin M was phosphorylated in
serine with isoelectric variants (Figure 1C).
T od e t e r m i n et h es y n e m i nl o c a l i z a t i o ni nE Sc e l l s ,w e
performed double immunofluorescence staining utilizing
synemin, Oct-3/4, cytokeratin 8 (K8), and SSEA-1 anti-
bodies. In order to study specifically the expression of
the synemin H isoform, we produced a polyclonal anti-
body with a polypeptide corresponding to the exon 4a
of human synemin, a specific fragment for synemin H
[4]. Western blotting analysis with proteins extracted
from the mouse bladder showed that this antibody
recognized specifically one band of 180 kDa, corre-
sponding to the synemin H isoform (Figure 2A). The
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Page 2 of 13immunocytochemistry study clearly showed the presence
of the synemin M protein in pluripotent ES cells expres-
sing Oct-3/4 (Figures 2C-E) and K8 (Figures 2F-H).
However, synemin H was never detected in undifferen-
tiated ES cells (Figure 2J) expressing the pluripotent ES
marker such as SSEA-1 (Figures 2I-K). It is remarkable
that neither synemin nor keratin was organized in fila-
mentous IF networks in pluripotent ES cells due to the
absence of their partners.
Change of synemin expression profile during neural
differentiation of ES cells
Since synemin isoform expression during the mouse
embryo development is complex [9], we decided to
study the possible change of synemin isoform expression
profile during ES cell neural differentiation. To achieve
this, cultured embryoid bodies (EBs) were treated with
retinoic acid (RA), an inducer of neural differentiation
[26-28]. The characteristics of differentiated ES cells
were then analyzed by RT-PCR, Western blotting and
immunochemistry. The expression of synemin H mRNA
as well as synemin L mRNA was detected in differen-
tiated ES cells along with synemin M, nestin, a specific
marker of neural precursor cells [29,30], and GFAP, a
specific marker of the glial cell lineage [31-34] (Figure
3A). However, the accumulation of synemin H mRNA
was less abundant than synemin M (the ratio of two iso-
forms is about 5). The appearance of these neural mar-
kers (nestin, GFAP, and b-III tubulin) in RA treated EBs
was also confirmed by Western blotting (Figure 3B). As
s h o w ni nF i g u r e3 B ,t h ei n d u c t i o no fs y n e m i nHa n d
synemin L was observed in differentiated ES cells after
RA treatment as well as an increase of synemin M.
When RA was added to EBs cells, the distribution of
synemin H and M was limited to the inner cells of the
EB and to a subpopulation of cells that migrated from
Figure 1 Characterization of synemin M in mouse ES cells. A, Analysis by RT-PCR of mRNA encoding synemins H and M isoforms and nestin
in USP-1 (lane 1), CGR8 (lane 2) and mouse embryo at E9.5 (lane 3). Synemin M mRNA was found in pluripotent ES cells, while synemin H and
nestin mRNAs were absent (lanes 1 and 2). Both synemin isoforms were detected in the 9.5-day-old embryo (lane 3). B, Characterization of
synemins H, M and Oct-3/4 proteins by Western blot. USP-1 (lane 1), CGR8 (lane 2) ES cells and the adult mouse bladder (lane 3) were used for
this study. Only the synemin M and Oct-3/4 were found in pluripotent ES cells (lanes 1 and 2). The synemin H was absent from undifferentiated
ES cells (lanes 1 and 2). The adult mouse bladder was used for a control (lane 3). C, Analysis of synemin in mouse ES cells by 2D-PAGE and
immunoblotting. Total protein extract of ES cells was separated by using pH 4-6 gradients IPG strips and 8% SDS/PAGE gels. Two spot trains of
synemin M with isoelectric points (pI) 5.1-5.2 and apparent 148-150 kDa molecular weights (MW) were characterized. Analysis of the
phosphorylation of synemin M revealed that two spot trains of synemin M contained phosphoserines (PSer) with isoelectric variants. Syn:
synemin.
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Page 3 of 13Figure 2 Immunofluorescence detection of synemin in mouse ES cells. A, Western blotting showing the specificity of synemin antibodies
with proteins extracted from mouse bladder. The antibody anti-synemin H detected one band of 180 kDa, corresponding to synemin H isoform
(lanes 1-2), and the anti-synemin H/M detected two bands 150 kDa and 180 kDa that correspond to H and M isoforms (lanes 3-4). GAPDH was
used for the loading control (lanes 5-6). B, Diagram illustrating the regions recognized by antibodies anti-synemin H and anti-synemins H/M. C-K,
Immunochemistry analysis demonstrating ES cells colonies labeled for Oct-3/4 (C), keratin 8 (F), SSEA-1 (I), synemin M (D, G) and synemin H (J).
Synemin M was present with Oct-3/4 (C-E) and keratin 8 (F-H) in pluripotent ES cells. No immunolabelling for synemin H was observed in
undifferentiated ES cells expressing SSEA-1 (I-K). Syn: synemin; K8: keratin 8. Bar = 20 μm.
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Page 4 of 13it, presumably radial glia cells. Differentiated ES cells pre-
sented an evident heterogeneity. We observed that
almost all of the neural precursors (90%) expressing syne-
min H and synemin M are nestin positive (Figures 4A-C,
G-I). The expression of synemin H in differentiated ES
cells was always associated with synemin M. During glial
cell differentiation, synemin H and M were expressed in
the immature astrocytes cells harboring low level of
GFAP (Figures 4D-F and data not shown). In contrast,
synemin H/M expression became extinct when astrocytes
express high level of GFAP (Figures 4J-L).
The neuronal differentiation in EBs was also observed
after RA treatment. These neuronal cells positive to b-
III tubulin did not contain the synemin H/M (Figures
4M-O). However, the antibody directed against synemin
L reacted with the neurons expressing b-III tubulin (Fig-
ures 4P-R).
Our in vivo analysis in the adult mouse brain also
confirmed the expression of synemins H and M in
multipotent neural stem cells. These synemin isoforms
were detected only in multipotent neural stem cells,
particularly in the subventricular zone of the lateral
v e n t r i c l e( F i g u r e5 A ) ,an e u r o g e n i cg e r m i n a ls i t ei n
adult mice [33,35]. However, GFAP was present in
these neural stem cells as well as in mature cortical
astrocytes (Figure 5B).
Synemin knockdown in mouse ES Cells by shRNA
lentiviral particles
To test whether synemin expression is functionally
required in ES cells, we carried out a synemin knock-
down experiment in mouse ES cells by shRNA lentiviral
particles transduction. The transduced mouse ES cell
clumps were selected via Puromycin dihydrochloride
selection, and then analyzed by qRT-PCR, Western blot
and immunocytochemistry. This study showed that
knocking down synemin (by 61.5%) decreased the
expression of keratin 8 by 42.6% at mRNA level (Figure
6A). A similar decrease was also detected by Western
blotting (Figure 6B) and immunocytochemistry analyses
(Figures 6I-N). Blast program (NCBI) analysis indicates
that three synemin siRNA sequences used in this experi-
ment do not share any homology with other genes, so
K8 decrease in this study is unlikely due to the direct
inhibition of synemin siRNA. The relationship between
synemin and K8 in ES cells remains to be studied. Syne-
min knockdown in mouse ES cells did not influence the
expression of Oct4, Nanog and SOX2 (Figures 6A-B).
This result was also confirmed by immunocytochemistry
study (Figures 6C-H). In order to determine whether
synemin knockdown can affect the growth ability of
mouse ES cells, MTT assay was used to test the changes
of cell growth ability. As seen in Figure 7, there is no
Figure 3 Analysis of synemin isoforms after neural differentiation of mouse ES cells. A, RT-PCR analysis of mRNA encoding synemins H, M
and L isoforms, nestin, and GFAP in retinoic acid (RA) treated (+) and control (-) EBs. Synemin M mRNA was found in both control and
differentiated ES cells, while synemin H, synemin L, nestin and GFAP mRNA were found only in differentiated ES cells (+) and absent in control
ES cells (-). B, Western blotting analysis of synemins (H, M and L), nestin, GFAP and b-III tubulin proteins extracted from RA treated (+) and
control (-) EBs. Synemins H and L, nestin, GFAP, and b-III tubulin proteins were detected in retinoic acid treated (+) EBs and absent in control (-)
EBs. An increase of synemin M protein was observed in EBs after retinoic acid treated (+). a-tubulin was used for the loading control. Syn:
synemin; Nes: nestin; bIII Tub: b-III tubulin; a-Tub: a-tubulin.
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Page 5 of 13Figure 4 Synemins H and M distribution during neural differentiation of mouse ES cells. Retinoic acid-treated EBs were immunolabelled
for synemin H (A, D), synemin H/M (G, J, M), synemin L (P), nestin (B, H), GFAP (E, K) and b-III tubulin (N, Q). The heterogeneity of differentiated
ES cells was observed. Synemin H and M were co-expressed with nestin in a subpopulation of neural precursors (A-C, G-I), also with GFAP in a
subpopulation of glia-astrocyte precursors harboring low level of GFAP (D-F). In contrast, synemin expression became extinct when astrocytes
expressing high level of GFAP (J-L). During neuronal differentiation, no synemin H or M was detected in the neuronal cell expressing b-III tubulin
(M-O). However, synemin L was co-expressed with b-III tubulin in neurons (P-R). Syn: synemin; Nes: nestin; bIII Tub: b-III tubulin. Bar = 20 μm.
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Page 6 of 13significant modification of cell proliferation in the shSyn
group when compared to the control group.
Discussion
The exact mechanisms underlying the developmental
changes in stem cell and precursor population are not
understood. The adult vertebrate CNS consists of four
major differentiated cell types: neurons, astrocytes, oli-
godendrocytes and ependymal cells. How these differen-
tiated cell types are generated during early
embryogenesis remains mostly unknown due to the
complexity of cell structure in this system, the lack of
specific cell surface markers to identify distinct cell
types and the presence of numerous amplifying cell
population in transit that rapidly generate early progeni-
tors. We demonstrated here that synemin expression is
characteristic of mouse ES cell lines in the undifferen-
tiated state and the neural stem cells at both mRNA
and protein levels. Our experiment showed that mouse
pluripotent ES cells expressed synemin M, prior to nes-
tin, which is considered as a marker of neural stem cells
[20,29,30]. Moreover, this expression was associated
with a common transcriptional signature that is shared
by stem cells. This signature includes the expression of
stem cell markers, such as homeobox protein Nanog, a
transcription factor that functions in concert with other
factors such as Oct4 and SOX2 to establish the self-
renewal of undifferentiated ES cells [36-38], Oct4, a
transcription factor restricted to totipotent and pluripo-
tent cells [39-41], and SSEA-1, an ES cell surface bio-
marker [42]. It has been reported that there is a strong
correlation between Oct4 gene expression and synemin
regulation. Knocking down Oct4 by RNAi resulted in a
dramatic decrease of synemin M [40]. Synemin knock-
down in mouse ES cells by shRNA lentiviral particles
did not modify the expression of Oct4, Nanog and Sox2
(Figures 6A-B) showing that synemin can not influence
these transcriptional factors. As Oct4 is required to
maintain the pluripotentiality and self-renewal of ES
cells and since synemin M expression is under its regu-
lation, this suggests that synemin M could be implicated
in ES cell maintenance. Synemin knockdown did not
influence the ES cell growth. The exact nature of how
synemin is implicated in the maintenance of mouse ES
cells remains to be studied.
Cytoskeletal proteins play important regulatory roles
in a variety of cellular processes including proliferation,
migration and differentiation. Among the three types of
cytoskeletal elements, two are clearly present in mouse
oocytes: microtubules and microfilaments, the presence
of IFs being more controversial. The organization and
role of the cytoskeletal networks (mainly microtubules
and microfilaments) during oogenesis, fertilization and
pre-implantation development of the mouse are
described given the importance of cell-cell interactions
and of the subcellular organization in events leading to
the formation of the first two lineages of the mouse
embryo [43]. In recent years, IFs have attracted much
interest, largely because their constitutive polypeptide
units are specifically expressed in various cell types and
Figure 5 Synemins H and M distribution in adult mouse
subventricular zone in vivo. Sections from adult mouse brain
were stained with antibodies against synemins H and M in green
(A) or GFAP in red (B). Synemins H/M were detected in the limited
neural stem cells of the subventricular zone (SVZ, arrowhead) and
the choroid plexus (arrow) of the adult mouse brain. GFAP was
present in neural stem cells of the SVZ and also in mature cortical
astrocytes. Overlay in C shows the co-localization of synemin with
GFAP in the neural stem cells.
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Page 7 of 13Figure 6 Synemin knockdown in mouse ES cells by shRNA lentiviral particles. A, Analysis of mRNA expression by qRT-PCR. Messenger RNA
was extracted from ES cells infected by control or synemin shRNA lentivirus (shSyn). The PCR analysis was performed with SYBR green PCR
technology. HPRT was used as a control gene for normalization. B, Western blotting analysis of synemins M (Syn M), Keratin 8 (K8) and Oct-3/4
proteins extracted from ES cells infected by control or synemin shRNA lentivirus (shSyn). GAPDH was used for the loading control. C-N,
Immunochemistry analysis demonstrating ES cells colonies labeled for Oct-3/4 (C, F), keratin 8 (I, L) and synemin M (D, G, J, M) in mouse ES cells
infected by control (C-E, I-K) or synemin shRNA lentivirus (shSyn, F-H, L-N). Synemin knockdown in mouse ES cells by shRNA lentivirus has no
influence on expression of Oct4, but decrease keratin 8 expression. Bar = 20 μm.
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H o w e v e r ,t h ep r e s e n c eo fI F si nE Sc e l l si sn o tc l e a r ,
and there is no evidence supporting a role for IF pro-
teins in ES cell. Cytokeratins seem to be the first IFs
expressed in embryogenesis [18,19]. Our findings repre-
sent the first evidence that synemin M could be a novel
characteristic of stem cells. Our functional study
demonstrated that synemin knockdown in ES cells by
shRNA lentiviral particle transduction also decreased
keratin 8 expression. However, their correlation in ES
cells is still not clear. In addition, our protein analysis
showed that pluripotent ES cells contain two spot
groups with isoelectric variants of synemin M (Figure
1C). These isoelectric variations of synemin M may
reflect differences on its phosphorylation level. In fact,
we have observed that two spot trains of synemin M
were phosphorylated (Figure 1C). It is known that IFs
are among the most abundant cellular phosphoproteins,
their physiologic phosphorylation is typically heteroge-
neous and implicated in the structural organization of
IFs [2,45]. Early studies indicated that synemin provides
temporal and spatial targeting of protein kinase A
(PKA) in adult and neonatal cardiac myocytes [14]. PKA
targeted to IFs could phosphorylate its substrates and it
was previously reported that the synemin avian ortholog
is phosphorylated by PKA [46]. Moreover, synemin itself
may be regulated through phosphorylation by the cataly-
tic subunit of PKA [14]. It is also noteworthy that the
cAMP/PKA pathway plays an important role in murine
ES cell self-renewal pathways. Directly inhibiting PKA
activity in the presence of LIF causes a decrease in Oct4
expression; however, in the absence of LIF, there is
increased Oct4 expression [47]. The further
investigation may be particularly attractive to identify
the mechanism by which the post-translational modifi-
cation of synemin protein is taken place during stem
cell differentiate.
During neural differentiation of ES cells evoked by
RA-treatment, the expression of synemin H was induced
in neural stem cells along with synemin M, nestin and
GFAP expression, which characterizes synemin H as a
potential marker of the neural stem cell differentiation.
Our in vivo analysis also confirmed the expression of
synemins H and M in multipotent neural stem cells in
the subventricular zone of the adult mouse brain, a
niche of the neural stem cells [33,35]. Furthermore, in
agreement with our previous data, synemin L is
expressed only in mature neurons [9,16]. This selectivity
suggests that the commitment of neural precursors to
form astroglia or neuron as early as stem cell differen-
tiation involves the direct regulation of the single syne-
min gene. We therefore believe that the production of
synemin proteins is closely associated with the early spe-
cialization of ES cells.
Conclusions
The work presented here demonstrates a complex regu-
lation of synemin gene expression and a developmental
stage specific production of each isoform in ES cells and
during their neural differentiation. The expression of
synemins is characteristic of mouse ES cell lines in the
undifferentiated state and the neural stem cells. Synemin
M was present in pluripotent ES cells, together with
Oct-3/4 and SSEA-1, prior to nestin, a known marker of
neural stem cells. Synemin H is up regulated during
retinoic acid induced neural differentiation and allows a
Figure 7 MTT assay was used to determine the effect of synemin knockdown on mouse ES cell proliferation activity at 18 and 42
hours culture. No significant modification of cell proliferation in the shSyn group when compared to the control group. OD: optical density.
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mitted stage. During neural differentiation there was
also a distinct expression of synemin H, M and L. Syne-
m i nHa n dMa r es p e c i f i cf o rt h eg l i a ll i n e a g ed u r i n g
neural differentiation, whereas synemin L characterized
only neuronal cells. The synemin knockdown in ES cells
has no influence on expression of Oct4, Nanog and
SOX2, but decreased keratin 8 expression. Taken
together, the findings herein represent the first evidence
that synemins might offer potentially novel and useful
markers for distinguishing multipotent ES cells from
undifferentiated neural stem cells and more committed
progenitor cells.
Methods
Cell culture
Two mouse ES cell lines were used during our work:
USP1 [48] and CGR8 [22]. USP1 ES cells were main-
tained in an undifferentiated state on mouse embryonic
fibroblast (MEF) feeder layer, mitotic inactivated with
mitomycin C (Sigma-Aldrich), in DMEM/F12 with 15%
(v/v) knockout serum replacement, 2 mM L-glutamine,
1% (v/v) nonessential amino acids, 0.1 mM b-mercap-
toethanol (Invitrogen), 40 μg/mL gentamicin sulfate
(Scheing-Plough) and 1000 U/mL of leukemia inhibitory
factor (LIF, Invitrogen). CGR8 murine ES cells were cul-
tured on 0,2% (w/v) gelatin (Sigma) coated tissue culture
plates in Glasgow’s modified Eagle’s medium supple-
mented with 10% (v/v) fetal calf serum, 2 mM L-gluta-
mine, 1% (v/v) nonessential amino acids, 0.1 mM b-
mercaptoethanol, 1 mM sodium pyruvate, 50 U/mL
penicillin, 50 mg/mL streptomycin (Invitrogen). 1000 U/
mL of LIF were added prior to use. All cultures were
incubated at 37°C in a humidified 5% CO2/95% air.
Formation and treatment of embryoid bodies (EBs)
A standard protocol for EB formation was used. Briefly,
USP1 ES cells and MEF cell monolayers were disso-
ciated with TrypLE™ Express (Invitrogen) and were pla-
ted on gelatin-treated dishes for 30 min to remove the
feeder cells. This procedure was repeated twice. CGR8
ES cells were used directly. For EBs formation, ES cells
(4 × 10
5/mL) were passed to a 6-well plate covered with
2% (w/v) gelatin (Sigma) and cultured for 48 h (d0-d2)
in ES medium as described above. Colonies were then
treated with TrypLE™ Express for 5 minutes at 37°C,
transferred to non-adherent plate dishes (2.5 × 10
5/mL)
with EB medium (DMEM/F12 medium with 15% (v/v)
fetal bovine serum (Invitrogen), 2 mM glutamine, 1% (v/
v) nonessential amino acids, 0.1 mM b-mercaptoethanol,
50 U/mL penicillin, 50 mg/mL streptomycin without
LIF). ES cells were plated as hanging drops on a lid of
10-cm non-adherent Petri dish. The lid was inverted
over the bottom of the dish filled with culture medium.
Spherical cell aggregates (EBs) were formed during 4
days (d3-d6). The resulting EBs were transferred into
Petri dishes (10-15 EBs per 6-cm dish) in 4 mL of the
EB medium, and treated with all-trans-retinoic acid (RA,
Sigma-Aldrich) during additional 4 days (from d7 to
d10) to induce neural differentiation. At d7, EBs were
divided in 2 groups: a) 0.02% (v/v) vehicle (DMSO) and
b) 2 μM RA. The medium was changed every two days.
For studying the neuronal differentiation, EBs were
plated onto 1 μg/mL laminin (Invitrogen) and 1 μg/mL
fibronectin (Invitrogen) coated dishes at day 10 and cul-
tured in DMEM/F12, with 1% (v/v) N2 supplement and
20 ng/mL of FGF-2 (Invitrogen) for additional 4 days.
Transduction of mouse ES cells by lentivirus
Mouse ES cells were cultured described above. The
shRNA lentiviral particles transduction was performed
according to the manufacturer’sp r o t o c o l( S a n t aC r u z ) .
Synemin shRNA lentiviral particles (sc-60526-V, Santa
Cruz) and control shRNA lentiviral particles (sc-108080,
Santa Cruz) were used for this study. Synemin shRNA
(m) Lentiviral Particles (sc-60526, Santa Cruz) is a pool
of 3 different shRNA plasmids. Corresponding siRNA
sequences are following:
A: Sense GCAAGACUAUGUUUGGAAAtt/Antisense
UUUCCAAACAUAGUCUUGCtt
B: Sense GCAAGGCAUUGCCUAUGAAtt/Antisense
UUCAUAGGCAAUGCCUUGCtt
C: Sense CAGUCACUCUGGAGUCAAAtt/Antisense
UUUGACUCCAGAGUGACUGtt
The transduced mouse ES cell clumps were selected
via Puromycin dihydrochloride selection (2 μg/ml), and
then analyzed by qRT-PCR, Western blot and
immunocytochemistry.
MTT assay
Different quantities (1 × 10
4,2×1 0
4,4×1 0
4 and 8 ×
10
4 cells) of three selected synemin knockdown and
control clones of mouse ES cells were cultured in 96-
well flat-bottomed plates in a triplicate pattern. After
eighteen or Forty-two hours, 20 μl 3-(4,5-Dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solu-
tion (5 mg/ml) was added to each well and incubated
for 3.5 h at 37°C. Then media were carefully removed,
200 μl of DMSO was added to each well and the plate
was agitated for 10 min at 37°C. Finally, Absorbance of
the converted dye of each well is measured at a wave-
length of 570 nm.
RT-PCR analysis
Total RNA from ES cells and mouse embryos was iso-
lated with Trizol Reagent (Invitrogen) and then treated
with RNase-free DNase (Qiagen). Aliquots (1 mg) of
total RNA were reverse-transcribed into cDNA with
de Souza Martins et al. BMC Cell Biology 2011, 12:51
http://www.biomedcentral.com/1471-2121/12/51
Page 10 of 13first-strand DNA synthesis kit (Roche Diagnostic) fol-
lowing the manufacturer’s instructions, and RT-PCR
products were amplified as previously described [9]. For
quantitative RT-PCR, the PCR analysis was performed
with SYBR green PCR technology (Light Cycler 480 sys-
tem, Roche Diagnostics). Primers were selected with the
Primer3 program http://biotools.umassmed.edu. Relative
quantification was achieved with the following equation:
R =2
ΔCttarget
(control-sample)-ΔCtref
(control-sample), Ct = cycle
threshold http://www.gene-quantification.de. HPRT was
used as the reference transcript. Results from 3 indepen-
dent RT-PCR analyses were expressed as the ratio
between mutant and control samples.
Primers for RT-PCR:
Synemin H or M: SynF (5’-AGTCAGGGAGCGT
TTCTGTGGACG-3’) and SynR (5’-ATCGCTTCTCGT
GTCGCTCAAATCC-3’);
Synemin L: SynLF (5’-AGAGTGATTGACAGCCTG-
GAGGAT-3’) and SynLR (5’-ACTGTGTGCAATTCTC-
CAGCCACC-3’);
Nestin: NesF (5’-AGGCTTCTCTTGGCTTTCCT-3’)
and NesR (5’-TGGATCATCAGGGAAGTGGT-3’);
GFAP: gfapF (5’-TGGATTTGGAGAGAAAGGTT
GAAT-3’) and gfapR (5’-CGATAGTGGTTAGCTTCGT
GTTTG-3’).
Primers for qRT-PCR:
Synemin: F (5’-GGTGGCCTCAGATGAGAAGA-3’)
and R (5’-GGCTTGCATGTCGGTATTTT-3’);
Keratin 8: K8F (5’-TCATCCTATGGGGGACTCAC-
3’) and K8R (5’-TCTTCACAACCACAGCCTTG-3’);
Keratin 18: K18F (5’-CTTGCTGGAGGATGGA
GAAG-3’)a n dK 1 8 R( 5 ’-GCCTCAGTGCCTCAGAA
CTC-3’)
Oct4: Oct4F (5’-GGGGCTGTATCCTTTCCTCT-3’)
and Oct4R (5’-GCTGGTGCCTCAGTTTGAAT-3’);
Nanog: NanogF (5’-GGACTTTCTGCAGCCTTACG-
3’) and NanogR (5’-TTTCACCTGGTGGAGTCACA-3’);
SOX2: Sox2F (5’-TACCTCTTCCTCCCACTCCA-3’)
and Sox2R (5’-CTGGGCCATGTGCAGTCTAC-3’).
Production of the antibody against synemin H
A cDNA fragment encoding the exon 4a (formerly
named intron IV) of human synemin [4], a specific frag-
ment for synemin H (amino acid residues 1151-1462)
was cloned into a pQE32 plasmid (Qiagen). The anti-
body anti-synemin H was produced as described pre-
viously [4]. The resulting rabbit antiserum was
characterized by Western blotting analysis. This anti-
body recognizes both human and mouse synemin H
isoforms.
Immunocytochemistry
ES cells were fixed with cold methanol during 5 min-
utes, washed with PBS, and then with PBS-Triton X-100
(0.1% v/v). Nonspecific sites were blocked with PBS +
5% (w/v) bovine serum albumin (BSA) during 45 min-
utes and incubated with primary antibodies for 90 min-
utes at room temperature (RT). The primary antibodies
were polyclonal anti-synemins H/M (1:400), anti-syne-
min H (1:400) and anti-synemin L (1:100) produced in
our laboratory [3], mouse monoclonal antibodies anti-
Oct-3/4 (1:100, Santa Cruz), anti-stage-specific embryo-
nic antigen-1 (SSEA-1, 1:100, Chemicon), anti-glial
fibrillary acidic protein (GFAP, 1:1000, Sigma), anti-nes-
tin (1:200, Chemicon), anti-b-III tubulin (1:500, Sigma)
or rat anti-keratin 8 (TROMA 1, 1:100) [48]. The sec-
ondary antibodies used were goat anti-mouse, anti-rat
or anti-rabbit immunoglobulins, coupled to the fluoro-
chromes Alex 488 (1:400, Invitrogen) or Cy3 (1:500,
Jackson) for 40 minutes at RT. Controls were performed
without the primary antibody.
One- and two-dimensional PAGE and Western blotting
Protein separation by 1D- or 2D-PAGE was carried out
as described previously [49,50]. For 2D-PAGE, total pro-
tein extract of ES cells was separated by using pH 4-6
gradients IPG strips and 8% SDS/PAGE gels. The pro-
teins were transferred onto nitrocellulose Hybond-C
+ or
PVDF (GE Healthcare) membranes and nonspecific pro-
tein-binding sites were blocked with TBS-T (20 mM
Tris-HCl, pH 7.5, 136.8 mM NaCl and 0.1% (v/v) Tween
20) containing 5% (w/v) non-fat milk. The blots were
reacted with primary antibodies against synemins H/M
(1:3000), synemin L (1:1000), nestin (1:1000), GFAP
(1:5000), b-III tubulin (1:3000), Oct-3/4 (1:500), GAPDH
(1:5000, Sigma) or a-tubulin (1:5000, Dako) in TBS-T
containing 2% (w/v) non-fat milk overnight at 4°C fol-
lowed by corresponding secondary antibodies anti-rabbit
or mouse IgG HRP-conjugated (1:5000; GE Healthcare).
The specific binding was revealed by an enhanced chemi-
luminescence (ECL) detection system (GE Healthcare).
For synemin phosphorylation study, the anti-phosphoser-
ine CDKs substrate antibody (1:1000, Cell Signaling) in
TBS-T containing 5% (w/v) BSA were used. This anti-
body detects phosphosérine in a (K/R)(S*)PX(K/R)
cyclin-dependent kinase (CDK) motif.
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